Primary and Secondary Breast Lymphoma

Focus on Epidemiology and Imaging Features

Riccardo Picasso, Alberto Tagliafico, Massimo Calabrese, Carlo Martinoli, Federico Pistoia, Anna Rossi, Federico Zaottini, Lorenzo Derchi

Research output: Contribution to journalArticle

Abstract

Aim of this study was to select all the cases of Primary (PBL) and Secondary (SBL) Breast Lymphoma from our breast unit since 01/01/2000, to obtain up-to-date data on the prevalence of this rare pathology and to analyze imaging features, with a special focus on CT. All pathological reports of breast biopsies performed from 01/01/2000 to 01/01/2019 were at first screened. Among them, we performed two different researches, looking for key words suggesting either a diagnosis of lymphoma or any other malignant disease. Using the Wiseman criteria, we identify PBL and SBL. All imaging features of PBL and SBL were analyzed. Prevalence of lymphoma amongst suspicious breast masses and amongst all breast malignancies were calculated. Out of 42,505 histopathology reports from mammary nodule biopsies, we found 19,354 malignancies. We were able to identify 11 patients affected by PBL (0,03% of suspicious breast lesions, 0.06% of breast malignancies), and 23 cases of SBL (0,05% of suspicious breast lesions, 0,12% of breast malignancies). Most common isotype in PBL was DLBC lymphoma, whereas in SBL that resulted Follicular lymphoma. In PBL group, we were able to retrieve images 7 CT or CT-PET study performed at diagnosis 7 US, 1 mammography and and 1 MR. In SBL group, we analyzed 14 CT/CT-PET examinations, 11 US studies and 3 mammography. PBL and SBL are rarer than considered until now. There is no definite imaging characteristic able to distinguish between these two pathologies and among them and breast cancer.

Original languageEnglish
JournalPathology and Oncology Research
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Lymphoma
Epidemiology
Breast
Mammography
Neoplasms
Pathology
Biopsy
Follicular Lymphoma
Breast Neoplasms
Research

Keywords

  • Breast
  • Epidemiology
  • Imaging
  • Lymphoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Oncology
  • Cancer Research

Cite this

Primary and Secondary Breast Lymphoma : Focus on Epidemiology and Imaging Features. / Picasso, Riccardo; Tagliafico, Alberto; Calabrese, Massimo; Martinoli, Carlo; Pistoia, Federico; Rossi, Anna; Zaottini, Federico; Derchi, Lorenzo.

In: Pathology and Oncology Research, 01.01.2019.

Research output: Contribution to journalArticle

@article{60605d8e5dfb4f56aafcd9ece8a5706b,
title = "Primary and Secondary Breast Lymphoma: Focus on Epidemiology and Imaging Features",
abstract = "Aim of this study was to select all the cases of Primary (PBL) and Secondary (SBL) Breast Lymphoma from our breast unit since 01/01/2000, to obtain up-to-date data on the prevalence of this rare pathology and to analyze imaging features, with a special focus on CT. All pathological reports of breast biopsies performed from 01/01/2000 to 01/01/2019 were at first screened. Among them, we performed two different researches, looking for key words suggesting either a diagnosis of lymphoma or any other malignant disease. Using the Wiseman criteria, we identify PBL and SBL. All imaging features of PBL and SBL were analyzed. Prevalence of lymphoma amongst suspicious breast masses and amongst all breast malignancies were calculated. Out of 42,505 histopathology reports from mammary nodule biopsies, we found 19,354 malignancies. We were able to identify 11 patients affected by PBL (0,03{\%} of suspicious breast lesions, 0.06{\%} of breast malignancies), and 23 cases of SBL (0,05{\%} of suspicious breast lesions, 0,12{\%} of breast malignancies). Most common isotype in PBL was DLBC lymphoma, whereas in SBL that resulted Follicular lymphoma. In PBL group, we were able to retrieve images 7 CT or CT-PET study performed at diagnosis 7 US, 1 mammography and and 1 MR. In SBL group, we analyzed 14 CT/CT-PET examinations, 11 US studies and 3 mammography. PBL and SBL are rarer than considered until now. There is no definite imaging characteristic able to distinguish between these two pathologies and among them and breast cancer.",
keywords = "Breast, Epidemiology, Imaging, Lymphoma",
author = "Riccardo Picasso and Alberto Tagliafico and Massimo Calabrese and Carlo Martinoli and Federico Pistoia and Anna Rossi and Federico Zaottini and Lorenzo Derchi",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s12253-019-00730-0",
language = "English",
journal = "Pathology and Oncology Research",
issn = "1219-4956",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Primary and Secondary Breast Lymphoma

T2 - Focus on Epidemiology and Imaging Features

AU - Picasso, Riccardo

AU - Tagliafico, Alberto

AU - Calabrese, Massimo

AU - Martinoli, Carlo

AU - Pistoia, Federico

AU - Rossi, Anna

AU - Zaottini, Federico

AU - Derchi, Lorenzo

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Aim of this study was to select all the cases of Primary (PBL) and Secondary (SBL) Breast Lymphoma from our breast unit since 01/01/2000, to obtain up-to-date data on the prevalence of this rare pathology and to analyze imaging features, with a special focus on CT. All pathological reports of breast biopsies performed from 01/01/2000 to 01/01/2019 were at first screened. Among them, we performed two different researches, looking for key words suggesting either a diagnosis of lymphoma or any other malignant disease. Using the Wiseman criteria, we identify PBL and SBL. All imaging features of PBL and SBL were analyzed. Prevalence of lymphoma amongst suspicious breast masses and amongst all breast malignancies were calculated. Out of 42,505 histopathology reports from mammary nodule biopsies, we found 19,354 malignancies. We were able to identify 11 patients affected by PBL (0,03% of suspicious breast lesions, 0.06% of breast malignancies), and 23 cases of SBL (0,05% of suspicious breast lesions, 0,12% of breast malignancies). Most common isotype in PBL was DLBC lymphoma, whereas in SBL that resulted Follicular lymphoma. In PBL group, we were able to retrieve images 7 CT or CT-PET study performed at diagnosis 7 US, 1 mammography and and 1 MR. In SBL group, we analyzed 14 CT/CT-PET examinations, 11 US studies and 3 mammography. PBL and SBL are rarer than considered until now. There is no definite imaging characteristic able to distinguish between these two pathologies and among them and breast cancer.

AB - Aim of this study was to select all the cases of Primary (PBL) and Secondary (SBL) Breast Lymphoma from our breast unit since 01/01/2000, to obtain up-to-date data on the prevalence of this rare pathology and to analyze imaging features, with a special focus on CT. All pathological reports of breast biopsies performed from 01/01/2000 to 01/01/2019 were at first screened. Among them, we performed two different researches, looking for key words suggesting either a diagnosis of lymphoma or any other malignant disease. Using the Wiseman criteria, we identify PBL and SBL. All imaging features of PBL and SBL were analyzed. Prevalence of lymphoma amongst suspicious breast masses and amongst all breast malignancies were calculated. Out of 42,505 histopathology reports from mammary nodule biopsies, we found 19,354 malignancies. We were able to identify 11 patients affected by PBL (0,03% of suspicious breast lesions, 0.06% of breast malignancies), and 23 cases of SBL (0,05% of suspicious breast lesions, 0,12% of breast malignancies). Most common isotype in PBL was DLBC lymphoma, whereas in SBL that resulted Follicular lymphoma. In PBL group, we were able to retrieve images 7 CT or CT-PET study performed at diagnosis 7 US, 1 mammography and and 1 MR. In SBL group, we analyzed 14 CT/CT-PET examinations, 11 US studies and 3 mammography. PBL and SBL are rarer than considered until now. There is no definite imaging characteristic able to distinguish between these two pathologies and among them and breast cancer.

KW - Breast

KW - Epidemiology

KW - Imaging

KW - Lymphoma

UR - http://www.scopus.com/inward/record.url?scp=85071146960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071146960&partnerID=8YFLogxK

U2 - 10.1007/s12253-019-00730-0

DO - 10.1007/s12253-019-00730-0

M3 - Article

JO - Pathology and Oncology Research

JF - Pathology and Oncology Research

SN - 1219-4956

ER -